LISA TINCHER: Open Payments
NPI 1063497915 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 14 payments from 8 companies in 2025. Trend: 2023 $298 · 2024 $143 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| ABBVIE INC. | 3 | $58 |
| Novo Nordisk Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, Auvelity, MAVYRET, Dexcom G6 Transmitter, Ozempic, SPRAVATO, Qelbree.
Industry payments across IN — which companies pay providers there.
